Integra Therapeutics (Integra Tx), a biotechnology company that develops state-of-the-art gene editing tools that improve the effectiveness of advanced genetic therapies, has closed an investment round of 1.5 million euros led by the Valencian venture capital manager Columbus Venture Partners. This investment completes the contribution of 4.5 million euros made in December by the funds, Invivo (Spain) and Takeda (Japan).
You can read the full story at the following link.
On 24 February, the Ordinary General Assembly of the Japan-Spain Business Circle (CEJE) was held at the Círculo Ecuestre de
On 24 February 2026, the president of the Japan-Spain Business Circle (CEJE), Jorge Lasheras, participated alongside lawyer Jaime J. Navarro,
On Friday, 20 February 2026, a large delegation of CEJE members attended the celebration of His Majesty the Emperor of
On Tuesday, 17 February, a delegation from the Japan-Spain Business Circle (CEJE) held an institutional meeting with the recently appointed
Following the recent elections in Japan, marked by significant economic and geopolitical challenges, Jorge Lasheras, president of the Japan-Spain Business
El Círculo Empresarial Japón España (CEJE) es la Asociación que incluye las empresas japonesas establecidas en España, así como las empresas españolas con intereses en Japón
CEJE Circulo Empresarial Japón España © 2026 -Todos los derechos reservados | Sitio web desarrollado por CleverBusiness Solutions S.L.
